| JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | RVI BIOTECNOLOGÍA | 43,81% | 25,36% | -21,09% | · |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 43,49% | 25,04% | -20,79% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 36,80% | 24,05% | -31,66% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 41,73% | 20,75% | -25,53% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,98% | 29,96% | -26,24% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 44,01% | 26,67% | -19,40% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 43,91% | 26,45% | -19,96% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,82% | 29,59% | -26,56% | · |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 14,28% | 19,10% | 4,92% | · |
| JPM TOTAL EMERGING MARKETS INCOME I2 (ACC) EUR | MIXTO AGRESIVO GLOBAL | 21,99% | · | · | · |
